Summary
Summary Molecular Therapy (NWI-BM078)
- Course
- Institution
Extensive summary of all lectures of the course molecular therapy (NWI-BM078).
[Show more]
Seller
Follow
roos1397
Reviews received
Content preview
Molecular therapyPersonalized healthcare
Principle of personalized medicine
- The right therapy for right patient at right intensity at right time
- Molecular biomarkers as key drivers of patient selection
- = personalized healthcare, precision medicine
B-RAF and personalized medicine in melanoma
- B-RAFV600E cells always grow and become cancer cells → mutation in kinase domain that
binds ATP → mutation makes it always active
- RAF inhibitors will block pathway, block cell growth and inhibit cancers (in mice) that have B-
RAFV600E mutation
- 60% of melanoma patients have B-RAFV600E mutation
- Basis of a personalized medicine
Biomarkers
- A characteristic that is objectively measured and evaluated as an indicator of normal
biological processes, pathogenic processes, or pharmacologic responses to a therapeutic
intervention
- Or ‘whatever works in adding value’
- Molecular biomarkers provide a molecular impression of a biological system (cell, animal,
human)
- Biomarkers can be various sorts of data, or combinations thereof
Biomarker data-based translational medicine in pharma
- Exposure – Does the compound get to the site of action?
- Mechanism – Does the compound cause its intended pharmacological/functional effects?
- Efficacy – Does the compound have beneficial effects on disease or clinical pathophysiology?
- Safety – What is the therapeutic window (how safe is the drug)?
- Responders – How do sources of variability in drug response in target population affect
efficacy and safety?
Pharma strategy based on personalized medicine
- Right target
- Right tissue
- Right safety
- Right patients
- Right commercial potential
1
,Role of molecular (omics) biomarker data in personalized healthcare
The power of omics in diagnostics
- Increase diagnostic yield
- Put biomarker change in context
Personalized healthcare in rare metabolic disorders
- Technology innovation is driving impact in personalized healthcare
- Crucial to combine different molecular views to understand human health and disease (X-
omics)
- Fast translational of biomarker research to implementation needed
- On personalized diagnosis
o Metabolic screening adds strongly to genetic screening in identifying mechanisms of
disease
- On personalized medicine
o Impressive effects of uridine therapy
o Increase quality of life for patient and family
o Frequent issues regarding expensive medication versus cheap supplements
- Advantages in using holistic omics methods in clinical diagnostics
Moving to personalized health(care)
- People are more than linear pathways
- Different genetic make-up and lifestyles
- Different environments
- Different risk factors
- Different preferences
3 key aspects of personalized health(care)
- What to measure?
- How much can it change?
- What should be the follow-up for me?
3 translational innovation gaps
- Research to research
- Research to diagnostics
- Research to society
2
,Translation is key in personalized healthcare
Personalized health(care) model
Afterthought: there is no single one reflection of health
- Funhouse mirror effect
- Multiple sources of your data
o Multiple omics
o Clinical chemistry
o Electronic patient dossier
o Wearables
o Digital biomarkers
o Commercial health tests
o Social media
o Surrounding
- Each are a skewed image of you
- How to deal with all of this for your personal health(care)?
Pharmacology and drug disposition
Pharmacology
- The science that is concerned with the use, effects, and modes of action of chemicals on the
function of living system
Pharmacotherapy
- What does the patient with the drug? → pharmacokinetics
3
, - What does the drug with the patient? → pharmacodynamics
Rational vs. evidence-based pharmacotherapy
- Rational pharmacotherapy → mechanism-based pharmacotherapy
- Evidence-based pharmacotherapy → it does not matter how it works, as long as it works
Pharmacological phases in pharmacotherapy
- Exposition phase → behavior of a substance in the environment, changes in the application
form, available for uptake
- Toxicokinetic phase → absorption, distribution, metabolism (toxification, detoxification),
excretion (ADME)
- Toxicodynamic phase → interactions with receptors or other (macro) molecules at the site
of the operation
Classification of pharmacological effects
Classical drug-receptor-interactions
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller roos1397. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R118,37. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
84669 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy summaries for 14 years now